CompletedNCT04011280
Smoking Cessation Medication for People With Serious Mental Health Conditions
About this title
Read the official source — NCT04011280Medication studyAges 18–70United StatesSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- La JollaSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: August 12, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 39
- Sponsor
- University of California, San Diego
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT04011280
- Official title
Show the full official title
Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
La Jolla
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of California, San Diego, a university.
Did this study involve medication?
Yes. The study involved medication, including Varenicline.
Who was this study for?
Listed age limits: 18 years to 70 years.
